SUMMARY ANSWER: In human SCO testes, both the amounts of GDNF mRNA per testis and the concentration of GDNF protein per Sertoli cell are markedly reduced as compared to normal testes.
Introduction
Spermatogonial stem cells (SSCs) are the foundation for male fertility and, thus, elucidating how these cells are regulated in men is fundamentally important to human reproductive biology and medicine. Essential in this regulation is the proper control of the balance between self-renewing replication of SSCs and their production of transitamplifying progenitor spermatogonia (de Rooij, 2001 ). This later celltype replicates a finite number of times, and then gives rise to fully differentiated spermatogonia. Most of our knowledge about mammalian SSCs and progenitor spermatogonia originates from studies of mice. The mouse testis contains slowly replicating SSCs that are sparsely distributed along seminiferous tubules. However, mouse progenitor spermatogonia replicate multiple times, thereby expanding the numbers of sperm that can be produced from a single stem cell (de Rooij, 2001) . There is abundant evidence that in the adult mouse, glial cell line-derived neurotrophic factor (GDNF) is an essential paracrine regulator of the numbers, replication and differentiation of SSCs and progenitor spermatogonia. Inhibition of GDNF signaling reduces the self-renewing replication of these stem cells, and promotes their differentiation (Parker et al., 2014) . These changes cause loss of SSCs and progenitor spermatogonia and the sequential depletion of increasingly mature spermatogenic cells. Eventually only somatic, Sertoli cells, remain and the testis is described histologically as being Sertoli cellonly (SCO) (Savitt et al., 2012) .
In contrast to the mouse, there are two populations of SSCs in humans and other primates: A pale spermatogonia, mitotically active stem cells that sustain spermatogenesis in a normal, mature seminiferous epithelium, and A dark spermatogonia, reserve stem cells that primarily replicate only after loss of substantial numbers of spermatogenic cells (van Alphen et al., 1988; Dym et al., 2009; Hermann et al., 2009 Hermann et al., , 2010 Gassei et al., 2014) . The progenitor spermatogonia of humans and other primates also differ from their murine counterparts because they divide only once or twice before differentiating into B spermatogonia (Ben-Yehudah et al., 2010) . However, although replication of progenitor spermatogonia is limited, the number of sperm produced per gram of primate testis is similar to the mouse. This has led to the conclusion that the densities of SSCs in seminiferous tubules of primates are markedly greater than in the mouse .
Despite the significant difference in the numbers of human and murine SSCs and progenitor spermatogonia, there is evidence in support of the hypothesis that GDNF plays an important in vivo role in the regulation of the human cells. Human Sertoli cells, the only cells in direct contact with SSCs, expresses GDNF mRNA (Davidoff et al., 2001; Ma et al., 2013) , and transcripts encoding the subunits of the GDNF receptor, GFRA1 and RET are detectable in spermatogonia isolated from prepubertal human testes as well as in spermatogonia obtained from patients diagnosed with obstructive azoospermia (Ma et al., 2013; Izadyar et al., 2011) . Furthermore, GFRA1, the ligand-binding domain of the GDNF receptor, is expressed by human A pale and A dark spermatogonia (Grisanti et al., 2009) . However, the number of human SSCs and progenitor spermatogonia that express GFRA1, and thus are potential targets for GDNF, is currently unknown. Our first objective was to resolve this issue.
The hypothesis that GDNF is an important regulator of human SSCs and progenitor spermatogonia predicts that expression of this growth factor by human Sertoli cells is sufficient to stimulate SSCs and progenitor spermatogonia. To test this prediction, we compared testicular GDNF mRNA levels in testes of men and mice. As mouse SSCs have an absolute requirement for GDNF (Meng et al., 2000; Ryu et al., 2005; Savitt et al., 2012; Parker et al., 2014) , we anticipated that if human SSCs have a similar requirement, testicular expression of GDNF mRNA would be similar in men and mice.
The results of those experiments led us to consider a potential role for GDNF in human male infertility. We were prompted by the fact that the testes of some men diagnosed with non-obstructive azoospermia exhibit an SCO histological phenotype, similar to what we have observed in mice that had been subjected to a temporary inhibition of GDNF signaling. This similarity led us to hypothesize that human Sertoli cells in SCO testes produce substantially less GDNF than they do in normal testes. Our second objective was to test that hypothesis.
Materials and Methods

Collection of samples for biological analysis
Normal human testes were collected from beating-heart donors and the histology of each testis was evaluated. Biopsies were obtained for analysis of RNA or protein. Infertile patients were clinically evaluated as previously described (Schlegel, 2004) . This evaluation included the measurement of serum FSH levels by the New York Hospital Laboratories. Testis biopsies of men who were infertile with SOC testes or with testes that exhibited maturation arrest (MA) of spermatogenesis were collected as part of standard clinical care during testicular surgical sperm extraction (Schlegel, 2004) . Part of the biopsy was used to prepare 5-micron hematoxylin and eosin-stained histological sections used to diagnose the cause of infertility; the other part was used for analysis of transcript or protein levels. Each patient gave informed consent for the use of a part of the biopsy for these analyses. A 15-40 mg sample of tissue from each patient was available for these later analyses. Biopsies destined for analysis of RNA or protein were flash frozen in liquid nitrogen immediately after collection. All identifiers were removed from human testes or testis biopsies before they were made available for analysis. The Institutional Review Boards of Weill Medical College of Cornell University, the University of Pittsburgh School of Medicine and the Johns Hopkins Bloomberg School of Public Health approved collection and analysis of human testes or testis biopsies.
We also analyzed GDNF mRNA expression in testes of 60-to 90-day old Bl6SJL/J male mice. Prior to organ collection animals were sacrificed by asphyxiation with CO 2 and cervical dislocation. The Institutional Animal Care and Use Committee of Johns Hopkins University approved the use of mice for our studies.
Tissue preparation and fixation
Human testes used to analyze UCHL1 + and GFRA1 + spermatogonia were shipped on ice in Belzer UW cold storage solution (Bridge to Life, Columbia, SC) to Johns Hopkins University from the University of Pittsburgh Medical Center. Seminiferous tubules were isolated~24 h after the donor's aorta was clamped. Human tubules were manually separated in pre-warmed Dulbecco's Minimal Essential Medium (DMEM)/F-12 (Invitrogen), fixed for 2 h in 4% paraformaldehyde at room temperature and washed in PBS (four times, 30 mins/wash). Results with human seminiferous tubules transported to Johns Hopkins were confirmed using seminiferous tubules that were fixed in Pittsburgh prior to shipment.
Key reagents used in these studies
We used Taqman assays to quantify mRNA levels in testes and antibodies to detect and/or quantify specific proteins. The sources and catalogue numbers for all key reagents are provided in Supplementary data, Table S1 . This table also lists the working concentration or dilutions for each antibody.
Quantification of transcripts encoding human GDNF, kit ligand, clusterin, DDX4 and GFRA1 or mouse GDNF Experiments described herein quantified human transcripts encoding GDNF and two other genes expressed by Sertoli cells, kit ligand (KITL) and clusterin (CLU). Transcripts encoding GFRA1, a marker of SSCs and progenitor spermatogonia were also assayed. Data for GDNF, KITL, CLU and GFRA1 were normalized to the amount of 18S rRNA in each sample. We measured the concentration of two to three messenger RNAs in each testis or testis biopsy. However, the total number of samples were sufficient to quantify transcripts in three to six independent samples of normal testes, SCO testes and testes exhibiting MA. Amounts of GDNF mRNA in mouse testes were quantified using Taqman primers and data were normalized to the amounts of 18S rRNA in the same samples. RNA was isolated from biopsies of normal testes or testes diagnosed with non-obstructive azoospermia using the Qiagen RNeasy Mini kit (Qiagen, Valencia, CA) and the integrity of each sample was confirmed by use of RNA nanochips and an Agilent BioAnalyzer 2100. cDNA was synthesized using the SuperScript III First Synthesis kit, using random hexamers as primers (Invitrogen, Carlsbad, CA). Due to its increased level of sensitivity, digital PCR was used to detect GDNF and GFRA1 message levels in human testes. Digital PCR was conducted using the Life Technologies QuantStudio 3D System and Taqman real-time PCR assays (Invitrogen). Transcripts encoding human KITL, CLU, DDX4 and 18S rRNA were quantified using human-specific Taqman assays and the StepOnePlus Real-Time PCR System (ThermoFisher Scientific, Waltham, MA). We also used this approach and mouse-specific Taqman assays to quantify mouse GDNF mRNA and 18S rRNA. A standard curve of sequence-verified cloned plasmids encoding each transcript was run for each assay. Controls included replacement of sample with water or with testis RNA that was subjected to the conditions for cDNA synthesis without the addition of reverse transcriptase. Data were normalized to the amount of 18S rRNA in each sample.
Quantification of GDNF protein in homogenates of testis biopsies GDNF protein was measured using the GDNF Emax ImmunoAssay System (Promega, Madison, WI). Frozen testis biopsies were weighed and then immediately homogenized in nine volumes of Promega Block and Sample Buffer ® supplemented with 10 μg/ml aprotinin, 1 μg/ml leupeptin and 1 mM PMSF. A 20 μl aliquot of the homogenate was flash frozen for later quantification of vimentin, which was used to normalize the amount of GDNF for the relative numbers of Sertoli cells represented in the sample. We centrifuged the remaining homogenate at 14 000g for 30 min, and collected the clear solution between the pellet and a lipid containing layer. GDNF was assayed in duplicate 30 μl aliquots of this clear solution. The amount of GDNF in each sample was expressed as ng of GDNF per μg of vimentin.
Quantification of vimentin in human testis homogenates
We used the concentration of vimentin in the homogenate of each testis biopsy to normalize amounts of GDNF for relative numbers of Sertoli cells. Sertoli cells are the primary testicular source of this intermediate filament protein (Kato et al., 2014) , and because of its abundance, vimentin can be easily assayed in the amounts of homogenate that were available. For each sample,15 μl of the homogenate was mixed with 345 μl of SDS sample buffer (62.5 mM Tris-HCl, pH = 6.8, 3% SDS, 10% glycerol), and DNA in the samples was sheared by repeatedly expressing this mixture through a tuberculin syringe. Samples were then centrifuged at 14 000g for 30 min to remove sperm heads, 10 μl of supernatant was mixed with 0.9 μl of β-mercaptoethanol, and heated for 5 min at 95°C. These samples along with a standard curve of recombinant human vimentin (31.25 ng to 500 ng, Novus Biologicals, Littleton, CO) were fractionated on 10% SDS-polyacrylamide gels, and transferred to Immobilon-P membranes (EMD Millipore, Billerica, MA). Membranes were blocked for 2 h in 4% nonfat dry milk in TTBS (Tris-buffered saline with 0.1% Tween 20), and shaken gently overnight at 4°C in anti-porcine vimentin, and then for 2 h at room temperature in IRDye800CM donkey anti-mouse IgG. Membranes were washed extensively with TTBS after incubation with each of the two antibodies. Data were collected with the Odyssey Infrared Imaging System (Li-Cor), and processed using Image Studio (Li-Cor).
Quantification of GDNF protein in individual sertoli cells
The amount of GDNF in individual Sertoli cells was determined by flow cytometry. Biopsies from three different testes with complete spermatogenesis were obtained from beating heart organ donors at Weill Cornell Medical Center. Biopsies from four different SCO testes were obtained surgically during testicular sperm extraction. Cells from each biopsy were analyzed separately. Single cell suspensions were prepared from the cadaveric testes with normal spermatogenesis and from biposies of SCO testes. Small biopsies were transferred into microcentrifuge tubes containing 0.5 ml of ice-cold DMEM supplemented with 10% fetal bovine serum (FBS). The biopsies were minced with sterile, sharp scissors and loaded onto disposable disaggregator Medicon unit with 50 µm separator mesh (BD Biosciences, San Jose, CA) filled with 0.5 ml of DMEM/10% FBS medium. The tubes that had contained the biopsies were washed with extra 0.5 ml medium and added to the Medicon, and samples were processed in the BD Medimachine for 50 s. The resulting cell suspensions were recovered with a 5 ml syringe without needle and filtered through 50 µm and then 30 µm Filcon units (BD) previously soaked with DMEM/10%FBS medium, and the presence of single cell suspensions was confirmed microscopically. Cells were washed with DMEM/10%FBS medium, centrifuged at 300 g for 5 min, and fixed in BD Cytofix fixation buffer for 20 min. Fixed cells were washed twice with BD Perm/Wash buffer and centrifuged at 500 g for 5 min. The cells then were permeablized for 10 min with Perm/Wash solution.
Cells were stained with fluorescently-labeled antibodies for GDNF and the Sertoli cell marker, SOX9 (Lan et al., 2013; Frojdman et al., 2000) . Aliquots of permeablized cells (500 000-1 000 000 cells) were immediately stained with an antibody for SOX9 and one of two different antibodies for GDNF (Supplementary data, Table S1 ). Anti-SOX9 was labeled with AF-647; anti-GDNF was labeled with AF-647. Following a 1 h roomtemperature incubation of the cell suspension with labeled antibodies, the cells were washed twice with DMEM/10%FBS medium and resuspended in 300 µl of staining solution (BD Biosciences).
Unstained and stained cells were analyzed on a BD Accuri C6 flow cytometer with automatic plate loader and shaker. Data (fluorescence, forward and side scatter for each cell) were managed with BD C6 Software Version 1.0 and FlowJo v10.2. Each sample of cells was subjected to two separate FACS analyses and 100 000 cells were recorded per analysis. Identical results were obtained with the two different antibodies to GDNF. Cells were analyzed with a BD Accuri™ C6 flow cytometer equipped with two solid-state lasers: 488 and 640 nm. The following optical filters were used: FL1 533/30 nm, FL2 585/40 nm, FL3 > 670 nm and FL4 675/25 nm. To insure reproducibility of results, experiments were replicated using two different antibodies to GDNF and each cell suspension was analyzed in duplicate. Data from 100 000 cells were recorded for each flow cytometry run. Data that were gathered included the amount of fluorescence from bound antibodies and cell size, as measured by side scatter. Data were analyzed using BD C6 Software Version 1.0 and FlowJo v10.2.
Immunohistochemistry and microscopy
We used previously described immunohistochemical protocols to identify GFRA1 + and/or UCHL1 + spermatogonia on seminiferous tubules isolated from normal human testes (Savitt et al., 2012; Gassei et al., 2014; Parker et al., 2014) . Seminiferous tubules were isolated manually, placed in netwells in a 12-well plate (Corning Inc. Catalogue no. 3520) and fixed for 2 h at room temperature in 4% PFA dissolved in PBS (pH = 7.4). During this and all other steps in the protocol, the plates were placed on an orbital shaker and the tubules subjected to gentle agitation. The tubules were then washed eight times for 15 min with PBS and stored at 4°C. To initiate the immunolabeling protocol, seminiferous tubules were washed for 5 min at RT with PBS, and then incubated at RT with PBS and 1% BSA (PBS-B) for 1h. Tubules then were incubated overnight with antibodies raised against UCHL1 and GFRA1 diluted in PBS-B (Supplementary data, Table S1 ). Controls were incubated with non-immune IgG. The next day, tubules were washed 6× for 15 min with PBSBT (0.1% Triton X-100 in 1% BSA per 100 ml PBS) and then incubated overnight at 4°C with Donkey anti-Rabbit Alexa Fluor 488 IgG and Donkey anti-goat IgG Alexa Fluor IgG 546 in PBSBT. On the last day, the tubules were washed 6× for 15 min with PBSBT.
Prior to mounting samples, four drops of clear nail polish were placed on the slide and allowed to dry, to create raised edges to prevent the cover slip from crushing the tubules. A few drops (2-3) of PBS were placed on the slide to which the tubules are added and separated using forceps. Any excess PBS was soaked up gently with a Kimwipe and the tubules coated with Vectashield (Vector Laboratories, H-1000). A coverslip was secured by on the slide edges with clear nail polish, and the slides were allowed to dry for at least 20 min before observing. Whole mounts of seminiferous tubules were optically sectioned (Z = 2.3 μm) using a Zeiss LSM 710 Confocal Microscope. The same exposure, aperture and gain were used for imaging negative controls.
We used iVision software (Biovision Technologies, Exton, PA) to facilitate enumeration of GFRA1 + and/or UCHL1 + cells as well as the surface area of tubules containing these cells (Savitt et al., 2012; Parker et al., 2014) . Tubules from three different organs donors were analyzed, and data were expressed as numbers of cells per mm 2 of tubule surface.
We also examined the distribution of vimentin in histological cross sections of normal human testes. Paraffin embedded histological sections (5 μm) of normal human testes were obtained from the Department of Pathology and Laboratory Medicine of Weill Cornell Medical School. Tissues were deparaffinized, rehydrated and incubated sequentially in 10% goat serum in PBS-1% BSA, in 1:1000 anti-vimentin (or control mouse IgG) in 10% goat serum in PBS-1% BSA, and then in 1:200 Alexa Fluor 594 goat anti-mouse IgG. The incubation in primary antibody was done overnight at 4°C. The incubation in secondary antibody was performed at room temperature for 30 min. Tissues were washed extensively in PBS-1% BSA after incubations in the primary and secondary antibodies. Slides were mounted in Vectashield with DAPI and examined by fluorescence microscopy.
Statistical analyses
Data were analyzed using GraphPad Prism Version 6.0 f (GraphPad Software, La Jolla, CA). Data obtained for message and protein levels were analyzed by ANOVA or an unpaired t-test using Welch's correction. Statistically significant differences were defined as P ≤ 0.05.
Results
Characterization of donors and of testis histology
De-identified clinical data for each donor are provided as Supplementary data, Table S2 . Biopsies of normal testes were obtained from beating heart organ donors and biopsies of infertile testes were obtained during testicular sperm extraction from patients. The age of the tissue donors ranged from 25 to 46 years. The histology of each biopsy was characterized by a board certified pathologist as normal, as exhibiting nonobstructive azoospermia with MA of spermatogenesis, or as exhibiting non-obstructive azoospermia with a SCO phenotype. Representative micrographs of each histological phenotype are provided in Supplementary data, Fig. S1 . Serum FSH levels were also measured for each infertile patient, and were significantly, 3-to 4-fold, higher than in men with normal spermatogenesis (Supplementary data, Fig. S2 ).
Enumeration and characterization of GFRA1
+ spermatogonia in human seminiferous tubules with normal spermatogenesis Grisanti et al. (2009) reported that the ligand-binding domain of the GDNF receptor, GFRA1, is expressed by human A pale and A dark spermatogonia, which have been described as the two human SSC populations. However, the abundance of these GFRA1
+ cell was not established, and whether GDNF potentially targets a large or small fraction of SSCs remained to be determined. Therefore, we used whole mount immunocytochemistry and confocal microscopy to identify and enumerate spermatogonia on human seminiferous tubules that express GFRA1, and we compared their numbers to numbers of cells expressing another marker of human SSCs, UCHL1 . Figure 1 shows confocal micrographs of the surface of a human seminiferous tubule immunostained for both UCHL1 and GFRA1. Images are shown for UCHL1 alone (Fig. 1A , F and J), for GFRA1 alone (Figs 1B, E, H and 5I) and for both proteins (Fig. 1C, D and G.) Optical sections through the middle of a human seminiferous tubule confirm these cells reside in periphery of the tubule (Supplementary data, Fig. S3 ). Data in Fig. 1 demonstrate that there is considerable heterogeneity in expression of UCHL1 and GFRA1. While some spermatogonia express both proteins, (Fig. 1C-F) , others express only one (Fig. 1 C, G-J). To quantify both the numbers of these cells on normal seminiferous tubules and the heterogeneity in the cellular expression of these two proteins, we quantified UCHL1 + and/or GFRA1 + spermatogonia per mm 2 of seminiferous tubule (Table 1 ). The results document that GFRA1 + spermatogonia are present in high density on normal human seminiferous tubules (813 cells per mm 2 of tubule surface). Since monkey and human testes A pale and A dark spermatogonia express GFRA1, these results suggest that there is a significant population of GDNF-responsive SSCs in normal human testes (Grisanti et al., 2009; Hermann et al., 2009) . However, our results also demonstrate that significantly more spermatogonia express UCHL1 than express GFRA1 (P = 0.004), and that most but not all GFRA1 + cells also express UCHL1.
A comparison of GDNF mRNA concentrations in human and mouse testes
The hypothesis that GDNF regulates human SSCs and progenitor spermatogonia predicts that expression of GDNF mRNA in human testes would be similar to its concentration in a species whose SSCs are known to be GDNF-dependent, the mouse (Meng et al., 2000; Ryu et al., 2005; Wu et al., 2009; Savitt et al., 2012; Parker et al., 2014) . To test this prediction, we quantified GDNF mRNA expression in normal adult mouse and human testes (n = 6 for both). Results confirmed this prediction (Fig. 2) .
Transcripts encoding GFRA1 are significantly reduced in the SCO testis
Our observations that human testes contain abundant GFRA1 + SSCs or progenitor spermatogonia and express GDNF mRNA at biologically significant levels suggest that as with many other species, this growth factor is one of the important regulators of human SSCs (Oatley and Brinster, 2012) . It follows that a significant reduction in the amount of GDNF produced by a human testis might cause loss and/or dysfunction of SSCs, and, consequently, the SCO histological phenotype. This proposition is consistent with results from our studies of the in vivo regulation of SSCs in mature mice. We have shown that when GDNF signaling is inhibited in vivo, SSCs cease self-renewing replication, they differentiate prematurely, and the resulting loss of stem cells eventually leads the testis to develop a SOC histological phenotype. Importantly, these events are mirrored in decreasing testicular GFRA1 mRNA levels (Savitt et al., 2012; Parker et al., 2014) . Therefore, as a first step to assess a possible relationship between testis production of GDNF and loss or dysfunction of SSCs, we compared GFRA1 mRNA expression by human testes with normal spermatogenesis with expression of this transcript in SCO testes. To assess if the SSCs in the SCO testis give rise to differentiated progeny, we also measured, DDX4 mRNA, which is expressed at high levels by human spermatocytes and spermatids (Castrillon et al., 2000) . Figure 3A shows that while GFRA1 mRNA is detectable in SCO testes, its expression is 9.8-fold lower than in normal testes (P = 0.003) (Fig. 3A) . In contrast, DDX4 mRNA expression is 890-fold lower (P < 0.001) (Fig. 3B) . Taken together, these results demonstrate that SSCs are present in the human SCO testis. However, these stem cells are reduced in number and/or in function, and few act as founders for spermatocytes or spermatids.
GDNF mRNA expression is substantially reduced in SCO testes
The results shown in Fig. 3A provided the impetus to test whether GDNF production was reduced in SCO testes. The first part of this test was to quantify GDNF mRNA in normal testes, in SCO testes and in testes exhibiting MA of spermatogenesis. Analysis of this later group allowed us to determine if reduced expression of this transcript was a general characteristic of an infertile testis, or potentially specific to the SCO phenotype. Since human Sertoli cells have been proven to produce GDNF, we also quantified transcripts encoding two other Sertoli cell products, KITL and CLU in order to gain some insight into whether a decrease in GDNF mRNA expression in an SCO testis represented a specific change or an overall change in Sertoli cell function (Pineau et al., 1993; Deshpande et al., 2010) . Figure 4A shows that in SCO testes, GDNF mRNA expression is reduced by 5.2-fold as compared to normal testes (P = 0.001). However, expression of this transcript was not decreased in testes that were infertile due to MA of spermatogenesis. Neither was there any difference between normal testes and testes exhibiting MA in expression of transcripts encoding KITL or CLU (Fig. 4B,C) . However, in contrast to GDNF, expression of these other two transcripts was significantly higher in SCO testes than in normal testes (P < 0.05). We suggest that these increases are due in part to the fact that Sertoli cells represent a higher percentage of the total cell population of an SCO testis than of a normal testis.
The amount of GDNF protein per sertoli cell is markedly reduced in SCO testes
Two different but complementary approaches were used to determine if the amount of GDNF per Sertoli cell is significantly reduced in SCO testes. The first used fluorescence activated cell sorting to examine GDNF levels in individual cells and to determine whether Sertoli cells were the primary source of GDNF in the human testis. Single cells suspensions were prepared from biopsies of normal and SCO testes, and Figure 3 Expression of GFRA1 mRNA and DDX4 mRNA in human testes with normal spermatogenesis and in human testes diagnosed with non-obstructive azoospermia with a Sertoli cell-only phenotype, NOA(SCO). GFRA1 mRNA was assayed by digital PCR; DDX4 mRNA was assayed by quantitative real-time PCR, and the amounts of both transcripts were normalized to the amount of 18S rRNA in each sample. Results for DDX4 mRNA are presented on a log scale. Data (n = 5/group) are expressed as mean + SEM and demonstrate that expression of both transcripts are significantly reduced in SCO testes. Figure 2 A comparison of the expression of GDNF mRNA by human and mouse testes. GDNF mRNA in human and mouse testes (n = 6 for both species) were quantified by use of digital PCR (human) and real-time quantitative PCR (mouse). Data (mean + SEM) are expressed as amount of GDNF mRNA normalized to the amount of 18 s rRNA in the same sample. Species-specific Taqman primers were used for this analysis.
immunostained for GDNF and for the Sertoli cell marker, SOX 9 (Lan et al., 2013) . During FACS analysis, single cells were identified by size, and fluorescence for SOX 9 and GDNF was quantified for a minimum of 100 000 single cells. Figure 5A is representative of results obtained from the analysis of three normal testes and four SCO testes, and with two different antibodies to GDNF. Analysis of normal testes (Fig. 5A ) demonstrates that GDNF is expressed by a single population of SOX 9 + cells, identifying them as Sertoli cell cells (Fig. 5A ). In contrast, we resolved two populations of SOX 9 + cells in SCO testes that differed in their GDNF content. Cells in the smaller of the two populations contained similar amounts of GDNF as Sertoli cells in normal testes. However, the more predominant population contained substantially less GDNF than Sertoli cells of normal testes. Consequently, the average amount of GDNF per Sertoli cell was significantly reduced in SCO testes (P < 0.001).
To complement data obtained by cell sorting, we measured GDNF concentration in biopsies of normal testes and of SCO testes. We also quantified vimentin, in order to normalize amounts of GDNF for relative numbers of Sertoli cells in each sample. We used vimentin for normalization because in human testis, only Sertoli cells express appreciable levels of this intermediate filament protein (Supplementary data, Fig. S4 ) and because of vimentin's abundance.
We measured both GDNF and vimentin in biopsies of five normal testes and in biopsies of five SCO testes. Results (Fig. 5B) indicate that amounts of GDNF per Sertoli cell in normal testes are 3.4-fold higher than in SCO testes (P = 0.014). Thus, two independent analytical methods demonstrate that the average Sertoli cell in an SCO testis contains substantially less GDNF than the same cell in a normal testis.
Discussion
Our experiments show that normal human testes contain a large pool of spermatogonia that express the ligand-binding domain of the GDNF receptor, GFRA1. Since in human and monkey testes, GFRA1 is expressed primarily by A pale and A dark spermatogonia, we propose that many of the GFRA1 + cells we detected were SSCs. It was therefore noteworthy that GFRA1 mRNA levels were reduced~10-fold in the human SCO testis, while DDX4 mRNA levels were reduced over 800-fold. Those data suggest that in comparison to normal testes, the number and/or function of SSCs are diminished in SCO testes, and that almost all of their stem cells fail to produce differentiated progeny. The major finding of our experiments is that this reduction in stem cell numbers and/or function is associated with a significantly diminished testis content of GDNF mRNA and a markedly reduced amount of GDNF protein per average Sertoli cell. We, therefore, conclude that in SCO testes Sertoli cells produce substantially less GDNF than they do in normal testes.
GFRA1
+ spermatogonia are abundant in the normal human testis
As noted in the introduction, there is a consensus that testes of humans and monkeys contain markedly higher numbers of SSCs per volume of testis than do mice, the primary mammalian model used to study these stem cells. Data presented in Table 1 support this consensus; there are  813 GFRA1 + spermatogonia per mm 2 of human seminiferous tubule surface. In contrast, the mature mouse testis contains~40 GFRA1 + spermatogonia per mm 2 of seminiferous tubule surface, and most of those cells are transit-amplifying progenitors and not stem cells (Parker et al., 2014) . However, despite the abundence of human GFRA1 + spermatogonia, more cells express UCHL1, suggesting that this marker is expressed further into the human spermatogenic lineage than is GFRA1. Finally, data in Table 1 demonstrate that only 65% of GFRA1 + spermatogonia also express UCHL1. This heterogeneity in the expression of two different stem cell markers is consistent with other analyses of SSCs and progenitor spermatogonia in humans, monkeys and mice (Grisanti et al., 2009; Hermann et al., 2009; Valli et al., 2014) .
Sertoli cells are the primary source of GDNF in the human testis and in the SCO testis these cells produce substantially less GDNF than do sertoli cells in a normal testis
In vivo, SSCs are regulated and sustained by the somatic cells that create the stem cell niche. It follows that the dysfunction of one of those somatic cells could degrade this niche function. There is general agreement on the importance of Sertoli cells to this niche, and when we began these experiments, we expected that these cells were the primary source of GDNF in the human testis. The foundation of this expectation was our demonstration that in the rat testis, only Sertoli cells contain detectable amounts of this growth factor (Johnston et al., 2011) . Furthermore, human Sertoli cells secrete GDNF in vitro (Ma et al., 2013) . However, recent studies demonstrate that the stromal, peritubular myoid, cells are a second, biologically significant source of GDNF in the mouse testis (Chen et al., 2014 (Chen et al., , 2016 . Those recent discoveries motivated our use fluorescence activated cell sorting to examine GDNF expression by single cells. Analysis of cells from normal human testes revealed a single population of cells, which expressed appreciable amounts of GDNF. These cells also expressed the definitive Sertoli cell marker, SOX9 (Frojdman et al., 2000, p. 565; Lan et al., 2013, p. 582) . In contrast, SCO testes contained two populations of GDNF-producing Sertoli cells, and the cells in the predominant population expressed substantially less GDNF than Sertoli cells in normal testes. These results were confirmed and expanded by measuring GDNF content in biopsies of five different normal testes and in biopsies of five different SCO testes. When data were normalized for numbers of Sertoli cells, as estimated by the amount of vimentin, we concluded that Sertoli cells in human SCO testes produce 3.4-fold less GDNF than their counterparts in normal testes. The potential impact of this decreased GDNF production on the number and function of SSCs is illustrated in studies of mice that have only one functional copy of the GDNF gene. In their studies of GDNF +/− mice, Meng et al. (2000) reported that at puberty many seminiferous tubules lacked spermatogonia and that in older animals, many tubules exhibited an SCO phenotype. While those investigators measured neither the levels of GDNF mRNA nor protein in GDNF +/− testes, studies of the brains of similar mice indicate that loss of one copy of the GDNF gene results in an~50% reduction in tissue levels of GDNF mRNA and protein (Pascual et al., 2008; Heermann et al., 2010) . We, therefore, assume that a similar decrease in GDNF mRNA and protein expression caused the loss of SSCs in GDNF +/− mice. It is, therefore, noteworthy that in human SCO testis, the reduction in average Sertoli cell production of GDNF is of a much greater magnitude (3.4-fold). However, not all Sertoli cells were abbarent. Our analysis of the GDNF content of individual cells suggests that a minority of Sertoli cells in SCO testis produce normal amounts of GDNF. This fact raises a number of questions that deserve to be answered in future experiments. Are the SSCs in an SCO testis concentrated near these normal Sertoli cells? If they are, why do not those stem cells give rise to spermatocytes and spermatids? And since it has been demonostrated of mice that GDNF is but one important factor acting in the SSC niche, what other factors act in the human niche and is their expression dysregulated in the SCO testis (Oatley and Brinster, 2012) ? Answers to these questions and our current demonstration that GDNF production is deficient in the SCO testis may open up new therapeutic avenues to the treatment of men who are infertile because their SSCs are diminished in number and/or abarrent in function. 
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